Rising prevalence of HIV-1 non-B subtypes in Belgium: 1983-2001

被引:42
作者
Snoeck, J
Van Laethem, K
Hermans, P
Van Wijngaerden, E
Derdelinckx, I
Schrooten, Y
van de Vijver, DAMC
De Wit, S
Clumeck, N
Vandamme, AM
机构
[1] Katholieke Univ Leuven, Rega Inst Med Res, Louvain, Belgium
[2] Univ Hosp Leuven, AIDS Reference Lab, Louvain, Belgium
[3] CHU St Pierre, Div Infect Dis, Brussels, Belgium
[4] Katholieke Univ Leuven, Univ Hosp, Louvain, Belgium
[5] Univ Utrecht, Med Ctr, Dept Virol, Utrecht, Netherlands
关键词
epidemiology; non-B subtypes;
D O I
10.1097/00126334-200403010-00009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This study documented the HIV-1 subtype distribution in 2 Belgian hospitals and determined predictive demographics for non-B subtypes. Overall, subtype B was the most prevalent subtype in this population, followed by subtypes A and C. Several recombinants were detected, circulating recombinants as well as new ones. We found a rise in non-B subtypes from 0% in 1983 to 57% in 2001. The Cochran-Armitage trend test (P < 0.001) as well as the correlation analysis (R = 0.71 P = 0.0006) was highly significant. Recombinants were also increasing in this patient population from 0% in 1983 to 10% in 2001, with good support from the statistical analyses (trend test P < 0.001; correlation analysis R = 0.67, P = 0.0016). Heterosexual route of infection, black African race, African origin of the virus, and year of diagnosis were predictors for infection with non-B subtypes in multivariate analysis. This analysis indicates that the prevalence of non-B subtypes and recombinants in this patient population is high and increasing. Gathering demographic and sequence information from newly diagnosed patients could be useful to further follow the spread of non-B subtypes in Belgium and Europe, but subtyping based on sequence information still remains the most reliable method.
引用
收藏
页码:279 / 285
页数:7
相关论文
共 32 条
[1]  
Balotta C, 2001, J ACQ IMMUN DEF SYND, V27, P499, DOI 10.1097/00126334-200108150-00012
[2]   Increasing diversity of HIV-1(M) serotypes in French blood donors over a 10-year period (1985-1995) [J].
Barin, F ;
Courouce, AM ;
Pillonel, J ;
Buzelay, L ;
Baudelot, J ;
Botte, C ;
Chamaret, S ;
Durand, F ;
Elghouzzi, MH ;
Lemaire, JM ;
Maisonneuve, P ;
Maniez, M ;
Moncharmont, P ;
Noel, L ;
North, ML ;
Piquet, Y ;
Rouzioux, C ;
Smilovici, W ;
Tirtaine, C .
AIDS, 1997, 11 (12) :1503-1508
[3]  
Böni J, 1999, J ACQ IMMUN DEF SYND, V22, P174
[4]  
CANE PA, 2001, 5 INT WORKSH HIV DRU
[5]   The AG recombinant IbNG and novel strains of group M HIV-1 are common in Cameroon [J].
Carr, JK ;
Torimiro, JN ;
Wolfe, ND ;
Eitel, MN ;
Kim, B ;
Sanders-Buell, E ;
Jagodzinski, LL ;
Gotte, D ;
Burke, DS ;
Birx, DL ;
McCutchan, FE .
VIROLOGY, 2001, 286 (01) :168-181
[6]   HIV-1 subtypes in Luxembourg, 1983-2000 [J].
Deroo, S ;
Robert, I ;
Fontaine, E ;
Lambert, C ;
Plesséria, JM ;
Arendt, V ;
Staub, T ;
Hemmer, R ;
Schneider, F ;
Schmit, JC .
AIDS, 2002, 16 (18) :2461-2467
[7]  
Dietrich U, 1997, AIDS, V11, P1532
[8]  
Fontaine E, 2001, J ACQ IMMUN DEF SYND, V28, P254, DOI 10.1097/00042560-200111010-00008
[9]   Longstanding presence in Belgians of multiple non-B HIV-1 subtypes [J].
Fransen, K ;
Buve, A ;
Nkengasong, JN ;
Laga, M ;
vanderGroen, G .
LANCET, 1996, 347 (9012) :1403-1403
[10]   The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin [J].
Gao, F ;
Robertson, DL ;
Morrison, SG ;
Hui, HX ;
Craig, S ;
Decker, J ;
Fultz, PN ;
Girard, M ;
Shaw, GM ;
Hahn, BH ;
Sharp, PM .
JOURNAL OF VIROLOGY, 1996, 70 (10) :7013-7029